Tokyo University of Pharmacy and Life Sciences

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. The University of Tokyo日本1
2. Hoshi University日本1
3. Pharmaceuticals and Medical Devices Agency日本1
4. National Center of Neurology and Psychiatry日本1
5. Yamagata University日本1
6. Global Nursing Research Center, The University of Tokyo日本1
7. Albert Einstein College of Medicine美国1
8. Suzuka University of Medical Science日本1

按月发文

逐年被引

最新文献

1. 1
   Factors influencing changes in medication-taking and driving behavior after warnings about prescription medications that prohibit driving: an online surveyBMC Public Health20225
2. 2
   Association between pre‐admission anticoagulation and in‐hospital death, venous thromboembolism, and major bleeding among hospitalized COVID ‐19 patients in JapanPharmacoepidemiology and Drug Safety20227
3. 3
   Parental drinking according to parental composition and adolescent binge drinking: findings from a nationwide high school survey in JapanBMC Public Health202015
4. 4
   LC/Tribrid Orbitrap Analysis of Phosphodiesterase-5 Inhibitors and Their Analogs as Adulterants in Dietary SupplementsFood Hygiene and Safety Science20192
5. 5
   The association between concerns toward adverse reactions during pre‐approval drug reviews and the post‐approval addition of clinically significant adverse reactions to package inserts: A retrospective analysis of pre‐approval drug review reports and safety updatesPharmacoepidemiology and Drug Safety20184

高被引文献

1. 1
   Parental drinking according to parental composition and adolescent binge drinking: findings from a nationwide high school survey in JapanBMC Public Health202015
2. 2
   Association between pre‐admission anticoagulation and in‐hospital death, venous thromboembolism, and major bleeding among hospitalized COVID ‐19 patients in JapanPharmacoepidemiology and Drug Safety20227
3. 3
   Factors influencing changes in medication-taking and driving behavior after warnings about prescription medications that prohibit driving: an online surveyBMC Public Health20225
4. 4
   The association between concerns toward adverse reactions during pre‐approval drug reviews and the post‐approval addition of clinically significant adverse reactions to package inserts: A retrospective analysis of pre‐approval drug review reports and safety updatesPharmacoepidemiology and Drug Safety20184
5. 5
   LC/Tribrid Orbitrap Analysis of Phosphodiesterase-5 Inhibitors and Their Analogs as Adulterants in Dietary SupplementsFood Hygiene and Safety Science20192

主要发表期刊